NCT03581370View on ClinicalTrials.gov

Short Infusion Versus Prolonged Infusion of Ceftolozane-tazobactam Among Patients with Ventilator Associated-pneumonia

PHASE3RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 20, 2018

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions
Ventilator-associated Pneumonia
Interventions
DRUG

1 hour infusion

Intravenous administration of ceftolozane-tazobactam (ZERBAXA®) : 2000 mg by infusion for 60 minutes every 8 hours.

DRUG

4 hours infusion

Intravenous administration of ceftolozane-tazobactam (ZERBAXA®) : 2000 mg by infusion for 4 hours every 8 hours

Trial Locations (1)

31059

RECRUITING

Service Réanimation Polyvalente - CHU Rangueil, Toulouse

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER